Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Centessa Pharmaceuticals
Private Company Edition: New capital for health care and life science innovations include a fund for royalty deals, additional anti-infective funding, early-stage money and public health-focused cash. Also, Day One reveals a $130m series B venture round and Notch closes an $85m series A round.
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
- Other Names / Subsidiaries
- Inexia Limited, Orexia Limited